Distinct role of p38 and c-Jun N-terminal kinases in IL-10-dependent and IL-10-independent regulation of the costimulatory molecule B7.2 in lipopolysaccharide-stimulated human monocytic cells

Journal of Immunology

Volumn 168, Issue 4, 2002, Pages 1759-1769

  Lim, Wilfred ^a   Ma, Wei ^a   Gee, Katrina ^a   Aucoin, Susan ^a   Nandan, Devki ^a   Diaz Mitoma, Francisco ^a   Kozlowski, Maya ^a   Kumar, Ashok ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CD86 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSTIMULATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION;

EID: 0037083487     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.4.1759     Document Type: Article

References (61)

1. The role of the CD28 receptor during T cell responses to antigen
2. CD28/B7 costimulation: A review
3. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation?
4. B70 antigen is a second ligand for CTLA-4 and CD28
5. The emerging role of CTLA-4 as an immune attenuator
6. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors
7. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics
8. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4
9. The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen
10. The role of cytokines, CTLA-4 and costimulation in transplant tolerance and rejection
11. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
12. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse
13. The role of B7-1/B7-2:CD28/CLTA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response
14. + tumor cells ate potent vaccines for stimulating tumor rejection in tumor-bearing mice
15. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
16. Selective regulation of cytokine induction by adenoviral gene transfer of IκBα into human macrophages: Lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-κB independent
17. Bacterial endotoxins and host immune responses
18. Comparative analysis of B7-01 and B7-2 costimulatory ligands: Expression and function
19. Differential modulation of B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype
20. Enhanced B7-2 gene expression by interferon-γ in human monocytic cells is controlled through transcriptional and post-transcriptional mechanisms
21. Signal transduction through MAP kinase cascades
22. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
23. Lipopolysaccharide induction of tissue factor in THP-I cells involves Jun protein phosphorylation and nuclear factor κB nuclear translocation
24. CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide
25. A synthetic inhibitor of the mitogen-activated protein kinase cascade
26. Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms
27. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-α
28. The p38 mitogen activated kinase pathway regulates the human IL-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages
29. Dysregulation of B7.2 (CD86) expression on monocytes of HIV-infected individuals is associated with altered production of IL-2
30. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-α: Role of the p38 and p42/44 mitogen-activated protein kinases
31. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor
32. Inhibition by dexamethasone of antigen-induced c-Jun N-terminal kinase activation in rat hasophilic leukemia cells
33. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-κB
34. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
35. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum. UV irradiation or heat
36. Integration of MAP kinase signal transduction pathways at the serum response element
37. T suppressor lymphocytes inhibit NF-κB-mediated transcription of CD86 gene in APC
38. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone
39. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor
40. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein
41. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components
42. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection
43. Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis
44. Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs
45. + T cells to Th1 cells requires MAP kinase JNK2
46. Conference highlight: Do T cells care about the mitogen-activated protein kinase signalling pathways?
47. Defective T cell differentiation in the absence of Jnk1
48. + thymocytes
49. JNK is required for effector T-cell function but not for T-cell activation
50. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: Evidence for Stat3-dependent and -independent pathways
51. Enbanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils
52. Stat3-dependent induction of p19INK4D by IL-10 contributes to inhibition of macrophage proliferation
53. Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase
54. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms
55. Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity
56. Induction of cyclooxygenase-2 by the activated MEKKI → SEKI/MKK4 → p38 mitogen-actlvated protein kinase pathway
57. Selective interaction of JNK protein kinase isoforms with transcription factors
58. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene
59. JNK1 is required for T cell-mediated immunity against Leishmania major infection
60. Glucocorticoids inhibit activation-dependent expression of costimulatory molecule B7-1 in human monocytes
61. Cloning and functional characterization of the 5′-regulatory region of the human CD 86 gene